What does CUSIP 00973N102 represent in this 13F holders report?

CUSIP 00973N102 is the security identifier for AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock used to aggregate holder disclosures.

How many institutions held AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock in Q4 2018?

52 institutional investors reported AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock for Q4 2018. Use the holders table for investor-level position and value details.

AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ)

CUSIP: 00973N102

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / Common Stock
Shares outstanding: 53,160,953
Total 13F shares: 6,194,754
Share change: +2,870,306
Total reported value: $30,783,708
Price per share: $4.97
Number of holders: 52
Value change: +$11,758,455
Number of buys: 39
Number of sells: 16

Quarterly Holders Quick Answers

What is CUSIP 00973N102?
CUSIP 00973N102 identifies AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 00973N102:

Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023

Top shareholders of AKTSQ - AKTIS ONCOLOGY, INC. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
HERALD INVESTMENT MANAGEMENT Ltd	13F	Company	1.1%	578,636	$4,565,000	—	30 Sep 2018	13F
VANGUARD GROUP INC	13F	Company	1.1%	564,292	$4,441,000	—	30 Sep 2018	13F
CQS Cayman LP	13F	Company	0.59%	313,735	$2,469,000	—	30 Sep 2018	13F
PRECEPT MANAGEMENT LLC	13F	Company	0.56%	300,000	$2,361,000	—	30 Sep 2018	13F
MISSION WEALTH MANAGEMENT, LP	13F	Company	0.56%	299,987	$2,361,000	—	30 Sep 2018	13F
SALEM INVESTMENT COUNSELORS INC	13F	Company	0.28%	149,275	$1,175,000	—	30 Sep 2018	13F
UBS Group AG	13F	Company	0.28%	146,894	$1,156,000	—	30 Sep 2018	13F
Financial Advocates Investment Management	13F	Company	0.27%	145,650	$1,146,000	—	30 Sep 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.24%	126,399	$995,000	—	30 Sep 2018	13F
D.A. DAVIDSON & CO.	13F	Company	0.21%	113,500	$893,000	—	30 Sep 2018	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	0.18%	94,909	$747,000	—	30 Sep 2018	13F
MYDA Advisors LLC	13F	Company	0.16%	85,000	$669,000	—	30 Sep 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.14%	76,831	$604,000	—	30 Sep 2018	13F
BENJAMIN F. EDWARDS & COMPANY, INC.	13F	Company	0.08%	43,200	$340,000	—	30 Sep 2018	13F
COMMONWEALTH EQUITY SERVICES, LLC	13F	Company	0.08%	42,899	$337,000	—	30 Sep 2018	13F
BlackRock Finance, Inc.	13F	Company	0.07%	39,866	$314,000	—	30 Sep 2018	13F
ELEMENT CAPITAL MANAGEMENT LLC	13F	Company	0.06%	32,840	$258,000	—	30 Sep 2018	13F
THOMPSON DAVIS & CO., INC.	13F	Company	0.05%	28,325	$223,000	—	30 Sep 2018	13F
Providence Capital Advisors, LLC	13F	Company	0.05%	24,456	$192,000	—	30 Sep 2018	13F
BlueCrest Capital Management Ltd	13F	Company	0.04%	20,577	$162,000	—	30 Sep 2018	13F
NORTHERN TRUST CORP	13F	Company	0.04%	20,460	$161,000	—	30 Sep 2018	13F
HBK Sorce Advisory LLC	13F	Company	0.03%	16,608	$131,000	—	30 Sep 2018	13F
IHT Wealth Management, LLC	13F	Company	0.03%	15,281	$120,000	—	30 Sep 2018	13F
STATE STREET CORP	13F	Company	0.03%	13,626	$107,000	—	30 Sep 2018	13F
Raymond James Financial Services Advisors, Inc.	13F	Company	0.03%	13,300	$105,000	—	30 Sep 2018	13F
Squarepoint Ops LLC	13F	Company	0.02%	11,000	$87,000	—	30 Sep 2018	13F
MORGAN STANLEY	13F	Company	0.02%	8,414	$66,000	—	30 Sep 2018	13F
FNY Investment Advisers, LLC	13F	Company	0.01%	7,300	$57,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.01%	6,400	$51,000	—	30 Sep 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.01%	6,100	$48,000	—	30 Sep 2018	13F
Advisor Group, Inc.	13F	Company	0.01%	3,410	$27,000	—	30 Sep 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0%	2,002	$16,000	—	30 Sep 2018	13F
Advisory Services Network, LLC	13F	Company	0%	2,000	$16,000	—	30 Sep 2018	13F
RBC Europe Ltd	13F	Company	0%	1,224	$9,633	—	30 Sep 2018	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0%	1,204	$9,475	—	30 Sep 2018	13F
Farmers & Merchants Trust Co of Chambersburg PA	13F	Company	0%	1,200	$9,000	—	30 Sep 2018	13F
ROYAL BANK OF CANADA	13F	Company	0%	1,000	$8,000	—	30 Sep 2018	13F
BARCLAYS PLC	13F	Company	0%	400	$3,000	—	30 Sep 2018	13F

Institutional Holders of AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) as of Q4 2018

As of 31 Dec 2018, AKTIS ONCOLOGY, INC. - Common Stock (AKTSQ) was held by 52 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 6,194,754 shares. The largest 10 holders included SILVERBACK ASSET MANAGEMENT LLC, Vanguard Group Inc, Herald Investment Management Ltd, Millrace Asset Group, Inc., First Eagle Investment Management, LLC, MISSION WEALTH MANAGEMENT, LP, UBS OCONNOR LLC, Financial Advocates Investment Management, COMMONWEALTH EQUITY SERVICES, LLC, and UBS Group AG. This page lists 52 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

Q4 2018 holders

Holder diff

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.